Open original FDA record ↗Recall record
- FDA identifier
- Z-0380-2019
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Nov 3, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Randox has previously issued a recall for Liquid Cardiac Control CQ5053 lot 4245CK under REC334 on June 8, 2018. The firm has now confirmed the Liquid Cardiac Controls CQ5051, CQ5052 and CQ5053 are no longer suitable for the control of the Troponin T assay due to unacceptable variation between vials.
Source facts
- Action
- On October 2, 2018, the firm notified distributors of the recall via Expanded Urgent Medical Device Correction email. Customers were informed that the recall was related to previous recall REC334 on June 8, 2018. The firm has confirmed that Liquid Cardiac Controls CQ5052 and CQ5053 are no longer suitable for the control of the Troponin T assay due to unacceptable variation between vials. Customers were advised to take the following actions: - Discontinue use of these products for the Quality Control (QC) monitoring of Troponin T assays. - Discuss the contents of this notice with your Medical Director. - Update kits with revised IFUs excluding Troponin T values and the attached important notice to prevent further use of the device in the QC of Troponin T assays. - Complete and return the vigilance response section of this form to technical.services@randox.com within five working days. - Contact your local Randox sales representative for alternative product details. You may contact the firm at technical.services@randox.com.
- Initiated
- 2018-10-02
- Root cause
- Under Investigation by firm
- Terminated
- 2019-05-30
- Distribution
- Distributed to IN, NY, PR, and WV.
- Recall number
- Z-0380-2019
- Recall status
- Terminated
- CDRH record ID
- 167599
- FDA record created
- 2018-11-03
- Recall event number
- 81159